MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Adenoma, Acidophil

(UMLS:C0001433)

Definition:: A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed)
UMLS ID:: C0001433
MeSH ID:: D000239

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.650.025|C04.557.470.035.025|C04.557.580.625.650.025

Synonym(s)

Adenoma, Acidophil

Acidophil Adenoma

Acidophil adenoma

Eosinophil Adenoma

Eosinophil adenoma

Pituitary Gland Acidophil Adenoma

adenoma, eosinophilic, pituitary

adenoma, growth hormone secreting

eosinophilic adenoma, pituitary

10.

growth hormone secreting adenoma

11.

pituitary adenoma, eosinophilic

12.

pituitary eosinophilic adenoma

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Piperonyl Butoxide		9688356	CTD
2	oxadiazon		26710982	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Neoplasms, Neuroepithelial	54.8%
2	Gliomatosis cerebri	54.8%
3	melanoma	54%
4	Carcinoid Tumor	49.6%
5	Paraganglioma	49%
6	Neurilemmoma	48.5%
7	Craniopharyngioma	42.3%
8	Neuroectodermal Tumor, Melanotic	42.3%
9	Cystadenoma	39.7%
10	Mesothelioma	39.7%
11	Hutchinson's Melanotic Freckle	39%
12	Melanoma, Amelanotic	39%
13	Malignant Carcinoid Syndrome	37.9%
14	Pheochromocytoma	37.1%
15	Ganglioneuroma	36.2%
16	Glioma	36.2%
17	Malignant Glioma	36.2%
18	Medulloblastoma	35.9%
19	Melanoma, Experimental	35.4%
20	leukemia	34.4%
21	Adenomatosis, Pulmonary	31.2%
22	Adenomatous Polyps	31.2%
23	Basal cell carcinoma	29.5%
24	Carcinoma, Papillary	29.5%
25	Squamous cell carcinoma	29.5%
26	Carcinoma, Basal Cell	29.5%
27	Carcinoma	29%
28	Epithelioma	29%
29	Meningioma	28.4%
30	Carcinoid Heart Disease	28%
31	Histiocytic Disorders, Malignant	27.6%
32	Chordoma	27.4%
33	Teratoma	27.4%
34	Germinoma	27.4%
35	Teratocarcinoma	27.4%
36	Astrocytoma	27%
37	Ependymoma	27%
38	oligodendroglioma	27%
39	Ganglioglioma	27%
40	gliosarcoma	27%
41	Anaplastic astrocytoma	27%
42	Anaplastic Oligodendroglioma	27%
43	Trophoblastic Neoplasms	26.4%
44	Cystadenocarcinoma	25.2%
45	Mucoepidermoid Carcinoma	25.2%
46	Carcinosarcoma	25.2%
47	Hemangiosarcoma	25.2%
48	lymphangiosarcoma	25.2%
49	Carcinoma, Ehrlich Tumor	24.2%
50	Carcinoma, Lewis Lung	24.2%
51	Retinoblastoma	23.8%
52	Neoplasms, Germ Cell and Embryonal	23.4%
53	Germ Cell Cancer	23.4%
54	Lymphoma	23.1%
55	Dermoid Cyst	22.9%
56	Glioblastoma	22.4%
57	Neuroblastoma	22.4%
58	Glioblastoma Multiforme	22.4%
59	Composite Lymphoma	22.2%
60	Neoplasms, Glandular and Epithelial	22.1%
61	Hamartoma	22%
62	Neoplasms, Hormone-Dependent	22%
63	Neoplasms, Multiple Primary	22%
64	Paraneoplastic Syndromes	22%
65	Precancerous Conditions	22%
66	Neoplasms, Second Primary	22%
67	Carcinoma, Lobular	21.8%
68	Neuroectodermal Tumors	21.4%
69	Carcinoma 256, Walker	21.4%
70	Acoustic Neuroma	21.1%
71	Bowen's Disease	21%
72	Leukemia, Plasma Cell	21%
73	Choriocarcinoma	20.9%
74	Leukemia, Experimental	20.8%
75	Hepatocellular Adenoma	20.4%
76	Ganglioneuroblastoma	20.2%
77	Acanthoma	20%
78	Adenofibroma	19.9%
79	Fibroadenoma	19.9%
80	Ameloblastoma	19.4%
81	Angiokeratoma	19.4%
82	Hemangioma	19.4%
83	hemangiopericytoma	19.4%
84	Lymphangioma	19.4%
85	Mesenchymoma	19.4%
86	Nevus	19.4%
87	Hepatoblastoma	19.4%
88	Mixed Tumor, Mullerian	19.4%
89	Angiofibroma	19.4%
90	Sarcoma	19.4%
91	Chondrosarcoma	19.2%
92	leiomyosarcoma	19.2%
93	liposarcoma	19.2%
94	synovial sarcoma	19.2%
95	Angiomyolipoma	19.2%
96	Clear Cell Sarcoma of Soft Tissue	19.2%
97	Alveolar Soft Part Sarcoma	19.2%
98	Sarcoma, Myeloid	19.2%
99	Adenocarcinoma	18.4%
100	Carcinoma in Situ	18.4%
101	Carcinoma, Transitional Cell	18.4%
102	Papilloma	18.4%
103	Pseudomyxoma Peritonei	18.4%
104	Papillomatosis	18.4%
105	Carcinoma, Large Cell	18.4%
106	Carcinoma, Small Cell	18.4%
107	Leukemia, Radiation-Induced	18%
108	Cyst	17.8%
109	Neoplastic Processes	17.8%
110	Neoplastic Syndromes, Hereditary	17.8%
111	Pregnancy Complications, Neoplastic	17.8%
112	Prolactinoma	17.8%
113	Growth Hormone-Secreting Pituitary Adenoma	17.8%
114	Neoplasms, Experimental	17.6%
115	Dysgerminoma	16.8%
116	Neuroma	16.8%
117	Seminoma	16.8%
118	Fibrosarcoma	16.3%
119	Osteosarcoma	16.3%
120	Vipoma	15.8%
121	Sarcoma, Experimental	15.8%
122	Endometrial Stromal Sarcoma	15.7%
123	Thymoma	15.7%
124	Plasmacytoma	15.6%
125	Malignant histiocytosis	15.5%
126	Histiocytic sarcoma	15.5%
127	Multiple Endocrine Neoplasia	15.1%
128	Leukemia L1210	14.8%
129	Leukemia P388	14.8%
130	Malignant Fibrous Histiocytoma	14.8%
131	Neoplasms, Radiation-Induced	14.7%
132	Optic Nerve Glioma	14.1%
133	Lymphangioleiomyomatosis	13.8%
134	Basal Cell Nevus Syndrome	13.7%
135	Neuroendocrine Tumors	13.5%
136	Rhabdomyosarcoma	13.4%
137	Giant Cell Tumor of Bone	13.4%
138	Neurofibrosarcoma	13.2%
139	Adenoid Cystic Carcinoma	13.1%
140	Adenocarcinoma, Clear Cell	13.1%
141	Cholangiocarcinoma	13.1%
142	Cervical Intraepithelial Neoplasia	13.1%
143	Hodgkin Disease	12.9%
144	Lymphoma, Non-Hodgkin	12.9%
145	Carcinoma, Pancreatic Ductal	12.9%
146	Adenoma, Acidophil	12.8%
147	insulinoma	12.6%
148	Nephroblastoma	12.3%
149	Paraneoplastic Encephalomyelitis	12.2%
150	Adenomatous Polyposis Coli	12.2%
151	Adenoma	12.1%
152	Mammary Neoplasms, Experimental	12%
153	Phyllodes Tumor	12%
154	Hemangioendothelioma	12%
155	Lipoma	12%
156	Myoma	12%
157	Myxoma	12%
158	Angiolipoma	12%
159	Myelolipoma	12%
160	Neoplasms, Bone Tissue	12%
161	Neoplasms, Fibrous Tissue	12%
162	Smooth Muscle Tumor	12%
163	Desmoplastic Small Round Cell Tumor	12%
164	Chondroma	12%
165	Enchondroma	12%
166	Dermatofibrosarcoma	11.9%
167	Dermatofibrosarcoma Protuberans	11.9%
168	Sarcoma 180	11.9%
169	Tuberous Sclerosis	11.7%
170	Abdominal Neoplasms	11.5%
171	Erythroplasia	11.5%
172	Follicular cyst	11.5%
173	Head and Neck Neoplasms	11.5%
174	Mucocele	11.5%
175	Pilonidal Cyst	11.5%
176	Soft Tissue Neoplasms	11.5%
177	Thoracic Neoplasms	11.5%
178	Thyroglossal Cyst	11.5%
179	Synovial Cyst	11.5%
180	Aberrant Crypt Foci	11.5%
181	Lymphomatoid Granulomatosis	11.3%
182	neurofibroma	11.2%
183	Primary amyloidosis	11.2%
184	Klatskin Tumor	10.5%
185	Alveolar rhabdomyosarcoma	10.5%
186	Hydatidiform Mole	10.4%
187	Carcinoma, Ovarian Epithelial	10%
188	Mesoblastic Nephroma	9.8%
189	Leukemia, Myelomonocytic, Chronic	9.6%
190	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.6%
191	Digestive System Neoplasms	9.6%
192	Endocrine Gland Neoplasms	9.6%
193	Eye Neoplasms	9.6%
194	Nervous System Neoplasms	9.6%
195	Bone neoplasms	9.3%
196	Leukoplakia	9.3%
197	Lymphocele	9.3%
198	Pancreatic Cyst	9.3%
199	Skin Neoplasms	9.3%
200	Hematologic Neoplasms	9.3%
201	Barrett Esophagus	9.2%
202	Breast Cyst	9.2%
203	Actinic keratosis	9.2%
204	Mediastinal Cyst	9.2%
205	Neoplasm Invasiveness	9.2%
206	Neoplasm Metastasis	9.2%
207	Neoplasm Recurrence, Local	9.2%
208	Parovarian Cyst	9.2%
209	Pericardial Cyst	9.2%
210	Splenic Neoplasms	9.2%
211	Thymic Cyst	9.2%
212	Carcinogenesis	9.2%
213	Myxoid cyst	9.2%
214	Metastasis	9.2%
215	Waldenstrom Macroglobulinemia	8.7%
216	Multiple Myeloma	8.7%
217	Multiple Endocrine Neoplasia Type 1	8.5%
218	fibroma	8.4%
219	Fibromatosis	8.4%
220	Osteoblastoma	8.4%
221	Osteoma	8.4%
222	Rhabdomyoma	8.4%
223	Chondromatosis	8.4%
224	Hemangioblastoma	8.4%
225	Lymphoma, Extranodal NK-T-Cell	8.4%
226	Nasopharyngeal carcinoma	8.3%
227	Mastocytosis	8.2%
228	Sturge-Weber Syndrome	8.2%
229	Gastrointestinal Stromal Tumors	8.1%
230	Hemangioma, Cavernous	8.1%
231	Leukemia, T-Cell	8%
232	Leukemia, B-Cell	8%
233	Adrenocortical carcinoma	8%
234	Lymphoma, Follicular	8%
235	T-Cell Lymphoma	8%
236	Mantle cell lymphoma	8%
237	Liver Neoplasms, Experimental	7.8%
238	Corpus Luteum Cyst	7.6%
239	Ovarian Cysts	7.6%
240	Parathyroid Neoplasms	7.6%
241	Peritoneal Neoplasms	7.6%
242	Thyroid Neoplasm	7.6%
243	Thyroid carcinoma	7.6%
244	Gastrinoma	7.2%
245	Glucagonoma	7.2%
246	granulosa cell tumor	7.1%
247	Renal Cell Carcinoma	7.1%
248	Papillary Renal Cell Carcinoma	7.1%
249	Carcinoma, Endometrioid	6.8%
250	Mastocytoma	6.8%
251	Pancreatic Neoplasm	6.7%
252	Mastocytosis, Systemic	6.7%
253	Leukemia, Myeloid, Chronic-Phase	6.7%
254	Choledochal Cyst	6.7%
255	Fibromatosis, Aggressive	6.6%
256	Fibromatosis, Abdominal	6.6%
257	Peutz-Jeghers Syndrome	6.5%
258	Retroperitoneal Neoplasms	6.5%
259	Tracheal Neoplasms	6.2%
260	Leukoplakia, Oral	6%
261	Paraneoplastic Cerebellar Degeneration	6%
262	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.6%
263	Leukemia, Large Granular Lymphocytic	5.6%
264	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.6%
265	Lymphoma, T-Cell, Cutaneous	5.6%
266	Lymphoma, AIDS-Related	5.6%
267	Enteropathy-Associated T-Cell Lymphoma	5.6%
268	Primary Effusion Lymphoma	5.6%
269	Denys-Drash Syndrome	5.5%
270	Leydig Cell Tumor	5.3%
271	Esophageal Neoplasms	5.3%
272	Mouth Neoplasms	5.3%
273	Central Nervous System Neoplasms	5.3%
274	Vascular Neoplasms	5.3%
275	Limbic Encephalitis	5.3%
276	Thymus Neoplasms	5.3%
277	Genital Neoplasms, Female	5.2%
278	Pancreatic Pseudocyst	5.2%
279	Lymphatic Metastasis	5.2%
280	Neoplasms, Unknown Primary	5.2%
281	Leukemic Infiltration	5.2%
282	Breast Neoplasms, Male	5.2%
283	Neoplasm Micrometastasis	5.2%
284	Triple Negative Breast Neoplasms	5.2%
285	Lambert-Eaton Myasthenic Syndrome	4.8%
286	Testicular Neoplasms	4.8%
287	Thyroid Nodule	4.6%
288	Dupuytren Contracture	4.5%
289	Adrenal Gland Neoplasms	4.4%
290	Gastrointestinal Neoplasms	4.4%
291	Genital Neoplasms, Male	4.4%
292	Liver neoplasms	4.4%
293	Uveal Neoplasms	4.4%
294	Urticaria Pigmentosa	4.4%
295	Urologic Neoplasms	4.4%
296	Mycosis Fungoides	4.4%
297	Lymphomatoid Papulosis	4.4%
298	Plasmablastic lymphoma	4.4%
299	Sebaceous Gland Neoplasms	4.3%
300	Spinal Neoplasms	4.3%
301	Bone Marrow Neoplasms	4.3%
302	Polycystic Ovary Syndrome	4.3%
303	Opsoclonus-Myoclonus Syndrome	4.3%
304	Xeroderma Pigmentosum	4.2%
305	Burkitt Lymphoma	4.2%
306	Myelitis, Transverse	3.8%
307	Nose Neoplasms	3.3%
308	Sezary Syndrome	3.3%
309	ovarian neoplasm	3.3%
310	Meningeal Neoplasms	3.2%
311	Pituitary Adenoma	3.1%
312	Pituitary Neoplasms	3.1%
313	Palatal Neoplasms	3.1%
314	Ear Neoplasms	2.8%
315	Eyelid Neoplasms	2.8%
316	Lung Neoplasms	2.8%
317	Pleural Neoplasms	2.8%
318	Cell Transformation, Viral	2.7%
319	Brain Neoplasms	2.7%
320	Salivary Gland Neoplasms	2.7%
321	Spinal Cord Neoplasms	2.7%
322	Tongue Neoplasms	2.7%
323	Uterine Neoplasms	2.7%
324	Vaginal Neoplasms	2.7%
325	Vulvar Neoplasms	2.7%
326	Uterine Cancer	2.7%
327	Fallopian Tube Neoplasms	2.7%
328	Zollinger-Ellison syndrome	2.6%
329	Pharyngeal Neoplasms	2.4%
330	Central Nervous System Cysts	2.3%
331	Bile Duct Neoplasms	2.3%
332	gallbladder neoplasm	2.3%
333	Intestinal Neoplasms	2.3%
334	Penile Neoplasms	2.3%
335	Prostatic Neoplasms	2.3%
336	Stomach Neoplasms	2.3%
337	Polycythemia Vera	2.3%
338	Meningeal Carcinomatosis	2.2%
339	Laryngeal neoplasm	2.1%
340	Bladder Neoplasm	2%
341	Kidney Neoplasm	2%
342	Ureteral Neoplasms	2%
343	Urethral Neoplasms	2%
344	Bronchial Neoplasms	1.9%
345	Multiple Pulmonary Nodules	1.9%
346	Supratentorial Neoplasms	1.9%
347	Endometrial Neoplasms	1.9%
348	Hypopharyngeal Neoplasms	1.6%
349	Pleural Effusion, Malignant	1.6%
350	Hypopharyngeal Cancer	1.6%
351	Parotid Neoplasms	1.6%
352	Prostatic Neoplasms, Castration-Resistant	1.6%
353	Nelson Syndrome	1.6%
354	Brain Stem Neoplasms	1.5%
355	Cecal Neoplasms	1.4%
356	Duodenal Neoplasms	1.4%
357	Nasopharyngeal Neoplasms	1.3%
358	Tonsillar Neoplasms	1.3%
359	Choroid Plexus Papilloma	1.3%
360	Cerebellar Neoplasms	1.3%
361	Colorectal Neoplasms	1.2%
362	Paranasal Sinus Neoplasms	1.1%
363	Radicular Cyst	1.1%
364	Appendiceal Neoplasms	1.1%
365	Colonic Neoplasms	1.1%
366	Rectal Neoplasms	1.1%
367	Maxillary Sinus Neoplasms	0.9%
368	Anus Neoplasms	0.8%
369	Sigmoid Neoplasms	0.8%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234